Literature DB >> 17146286

Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1.

P Andreas Jonsson1, Karin S Graffmo, Thomas Brännström, Peter Nilsson, Peter M Andersen, Stefan L Marklund.   

Abstract

Mutant human CuZn-superoxide dismutases (hSOD1s) cause amyotrophic lateral sclerosis (ALS). The most common mutation is the wild type-like D90A and to explore its properties, transgenic mice were generated and compared with mice expressing wild-type hSOD1. D90A hSOD1 was both in vivo in mice and in vitro under denaturing conditions nearly as stable as the wild-type human enzyme. It appeared less toxic than other tested mutants, but mice homozygous for the transgene insertion developed a fatal motor neuron disease. In these mice, the disease progression was slow and there were bladder disturbances similar to what is found in human ALS cases homozygous for the D90A mutation. The homozygous D90A mice accumulated detergent-resistant hSOD1 aggregates in spinal cords, and abundant hSOD1 inclusions and vacuoles were seen in the ventral horns. Mice expressing wild-type hSOD1 at a comparable rate showed similar pathologic changes but less and later. Hemizygous D90A mice showed even milder alterations. At 600 days, the wild-type hSOD1 transgenic mice had lost more ventral horn neurons than hemizygous D90A mice (38% vs 31% p < 0.01). Thus, wild-type hSOD1 shows a significant neurotoxicity in the spinal cord, that is less than equal but more than half as large as that of D90A mutant enzyme.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146286     DOI: 10.1097/01.jnen.0000248545.36046.3c

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  41 in total

1.  Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.

Authors:  Per Zetterström; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Stefan L Marklund
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

2.  Misfolded SOD1 is not a primary component of sporadic ALS.

Authors:  Sandrine Da Cruz; Anh Bui; Shahram Saberi; Sandra K Lee; Jennifer Stauffer; Melissa McAlonis-Downes; Derek Schulte; Donald P Pizzo; Philippe A Parone; Don W Cleveland; John Ravits
Journal:  Acta Neuropathol       Date:  2017-02-28       Impact factor: 17.088

Review 3.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

4.  Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models.

Authors:  Per Zetterström; Heather G Stewart; Daniel Bergemalm; P Andreas Jonsson; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Mikael Oliveberg; Stefan L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

5.  Characterization of a covalent polysulfane bridge in copper-zinc superoxide dismutase .

Authors:  Zheng You; Xiaohang Cao; Alexander B Taylor; P John Hart; Rodney L Levine
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

6.  Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.

Authors:  Karin Forsberg; P Andreas Jonsson; Peter M Andersen; Daniel Bergemalm; Karin S Graffmo; Magnus Hultdin; Johan Jacobsson; Roland Rosquist; Stefan L Marklund; Thomas Brännström
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

7.  Composition of soluble misfolded superoxide dismutase-1 in murine models of amyotrophic lateral sclerosis.

Authors:  Per Zetterström; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Stefan L Marklund
Journal:  Neuromolecular Med       Date:  2012-10-18       Impact factor: 3.843

8.  Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis.

Authors:  Daniel Bergemalm; Karin Forsberg; P Andreas Jonsson; Karin S Graffmo; Thomas Brännström; Peter M Andersen; Henrik Antti; Stefan L Marklund
Journal:  Mol Cell Proteomics       Date:  2009-04-08       Impact factor: 5.911

9.  Protein charge ladders reveal that the net charge of ALS-linked superoxide dismutase can be different in sign and magnitude from predicted values.

Authors:  Yunhua Shi; Alireza Abdolvahabi; Bryan F Shaw
Journal:  Protein Sci       Date:  2014-08-07       Impact factor: 6.725

10.  Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.

Authors:  Mercedes Prudencio; P John Hart; David R Borchelt; Peter M Andersen
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.